Previous 10 | Next 10 |
2023-08-07 20:58:05 ET ICU Medical, Inc. (ICUI) Q2 2023 Results Conference Call August 07, 2023 4:30 PM ET Company Participants John Mills - Managing Partner, ICR Vivek Jain - Chairman, CEO Brian Bonnell - CFO Conference Call Participants Jayson Bedfo...
2023-08-07 16:19:54 ET ICU Medical press release ( NASDAQ: ICUI ): Q2 Non-GAAP EPS of $1.88 beats by $0.28 . Revenue of $549.3M (-2.1% Y/Y) misses by $13.6M . Fiscal Year 2023 GuidanceFor Fiscal Year 2023 the Company estimates GAAP net loss to be in the range o...
SAN CLEMENTE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2023. Second Quarter 2023 Results Second quarte...
SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call. The Company will release its s...
2023-06-15 02:23:29 ET Summary ICU Medical has caught a bid into FY'23, curling up 21% off lows. The economic characteristics of ICUI remain in situ, in my opinion. Therefore, the investment opinion gravitates towards a neutral view. Net-net, reiterate hold. Inve...
2023-05-10 02:10:00 ET Summary A punishing 2022 for Meta Platforms created a valuation opportunity - one that has paid off as it becomes the top contributor year-to-date for the Morningstar Wide Moat Focus Index. April was a subdued month - at least relative to the volatility seen...
2023-05-09 01:13:07 ET ICU Medical, Inc. (ICUI) Q1 2023 Earnings Conference Call May 08, 2023, 16:30 PM ET Company Participants John Mills - Managing Partner, ICR, Inc. Vivek Jain - Chairman and Chief Executive Officer Brian Bonnell - Chief Financial Officer ...
2023-05-08 16:17:15 ET ICU Medical press release ( NASDAQ: ICUI ): Q1 GAAP EPS of -$0.41 misses by $0.18 . Revenue of $568.65M (+4.7% Y/Y) beats by $3.35M . For further details see: ICU Medical GAAP EPS of -$0.41 misses by $0.18, revenue of $568.65M beats...
SAN CLEMENTE, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended March 31, 2023. First Quarter 2023 Results First quarter ...
SAN CLEMENTE, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2023 earnings release and conference call. The Company will release its f...
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...